Figure 1. Hypersensitivity-related Symptoms Reported With Greater Than Or Equal To 10% Frequency In Clinical Trials (n = 206 Patients) (11c3ad29 D59d 463b Beac 46628d5710c4 01)
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ziagen (NDC 53808-0811). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.